The myxoid liposarcoma was reclassified as a lipoblastoma due to absence of the pathognomonic myxoid liposarcoma FUS-DDIT3 fusion and presence of a HAS2-PLAG1 fusion. This evidence concerns the gene HAS2 and myxoid liposarcoma.